Eukaryotic translation initiation factors (eIFs) as novel biomarkers in bladder cancer

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO 11959918
APP PUB NO 20210025891A1
SERIAL NO

16911226

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a method of diagnosing bladder cancer in an individual. Further, the present invention relates to a method of determining the course of bladder cancer in an individual. Furthermore, the present invention relates to a kit for diagnosing bladder cancer in an individual or determining the course of bladder cancer in an individual.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • OTTO-VON-GUERICKE-UNIVERSITÄT MAGDEBURG

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Haybäck, Johannes Innsbruck, AT 2 0
Luzha, Jeton Magdeburg, DE 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Oct 16, 2027
7.5 Year Payment $3600.00 $1800.00 $900.00 Oct 16, 2031
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 16, 2035
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00